Tuesday July 25th 2017

U.S. Supreme Court agrees to hear Teva Pharmaceutical’s appeal related to COPAXONE patent

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Supreme Court has granted the Company’s COPAXONE® certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808 (the “‘808 patent”).

Originally posted here:  

U.S. Supreme Court agrees to hear Teva Pharmaceutical’s appeal related to COPAXONE patent

Leave a Comment

More from category

12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging
12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging

/About-the-Society/News/12-National-Patient-Advocacy-Organizations-Urge-Se [Read More]

Low vitamin D may affect recovery of injured corneas
Low vitamin D may affect recovery of injured corneas

Injury or disease in combination with too little vitamin D can be bad for the window to your eyes. The three-layer, [Read More]

CUMC researchers capture first snapshot of key brain receptor in action
CUMC researchers capture first snapshot of key brain receptor in action

Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype [Read More]

Contact Your Senators About Health Care
Contact Your Senators About Health Care

/About-the-Society/News/Contact-Your-Senators-About-Health-Care [Read More]

Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS
Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS

/About-the-Society/News/Paper-Published-on-Recommendations-for-Speeding-Re [Read More]